Asia Pacific Radiopharmaceuticals Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 1.76 Billion |
 Market Size (Forecast Year) |
USD 2.73 Billion |
 CAGR |
% |
| Major Markets Players |
> 亚太放射性药物市场细分，按类型（诊断放射性药物和治疗放射性药物）、应用（诊断和治疗）、药物类型（仿制药和品牌药）、来源（核反应堆、回旋加速器等）、最终用户（医院、诊断中心、癌症研究机构、门诊手术中心等） - 行业趋势和预测到 2031 年。
亚太放射性药物市场分析及规模
亚太地区角膜植入物市场受到多种因素的推动，包括角膜疾病患病率不断上升、人口老龄化加剧、技术进步、对微创手术的需求不断增长、对角膜移植的认识不断提高、政府举措和资金投入、混合型和散光型晶状体的采用率不断提高、交联手术越来越受欢迎、角膜植入物适应症不断扩大以及促进创新的竞争环境。这些因素共同推动了对角膜植入物的需求，尤其是在发达国家，因为患者寻求有效治疗视力障碍和圆锥角膜、福克斯营养不良和人工晶状体大泡性角膜病变等疾病。
Data Bridge Market Research 分析称，亚太放射性药物市场预计将从 2023 年的 17.6 亿美元增至 2031 年的 27.3 亿美元，在 2024 年至 2031 年的预测期内，复合年增长率为 5.7%。
|
报告指标 |
细节 |
|
预测期 |
2024 至 2031 年 |
|
基准年 |
2023 |
|
历史岁月 |
2022（可定制 2016-2021） |
|
定量单位 |
收入（十亿美元） |
|
涵盖的领域 |
类型（诊断放射性药物和治疗放射性药物）、用途（诊断和治疗）、药物类型（仿制药和品牌药）、来源（核反应堆、回旋加速器等）、最终用户（医院、诊断中心、癌症研究机构、门诊手术中心等） |
|
覆盖国家 |
中国、日本、澳大利亚、韩国、新加坡、印度、印度尼西亚、菲律宾、马来西亚、越南和亚太地区其他地区 |
|
涵盖的市场参与者 |
Cardinal Health、Advanced Accelerator Applications、Lantheus、Curium、GE HealthCare、Jubilant Radiopharma（Jubilant Pharma 旗下公司）、Ansto、Eli Lilly And Company、Bayer AG、Siemens Healthcare Gmbh、中国、isotope & Radiation Corporation、Bracco、NTP、Eckert & Ziegler、Eczacıbaşı-Monrol、IBA Worldwide、BWX Technologies. Inc、Isotope JSC、Sterigenics US, LLC 等等。 |
市场定义
放射性药物含有放射性物质和一种或多种成分，用于诊断、确定疾病阶段、监测治疗或提供治疗。放射性药物包括一组用于诊断或治疗干预的放射性药剂。放射性药物是含有放射性核素的药物。大多数放射性药物是放射性核素或放射性核素与作为载体并决定定位和生物分布的生物活性分子或药物的组合。
亚太放射性药物市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
诊断和临床应用对放射性药物的需求日益增长
放射性药物已成为帮助诊断器官和治疗病理疾病的必不可少的药物。它们用于诊断成像和放射治疗。诊断放射性药物不具有药理作用，并且其给药也不被认为与相关的临床副作用有关。
临床使用的放射性药物数量正在迅速增加，从而使医学界能够更好地获取有关不同类型肿瘤特征的详细信息。放射性核素也因提供越来越多的恶性疾病的缓解和治愈治疗而变得越来越重要。
例如，
- 2024 年 2 月，根据国际原子能机构发表的文章，放射性药物用于诊断，通过施用发射伽马光子的放射性化合物，这些光子穿透人体并被外部摄像机检测到，从而产生目标组织或器官的图像。这些图像有助于检测肿瘤、评估器官功能以及诊断癌症和心血管疾病等病症。与 X 射线不同，放射性药物通常需要等待一段时间才能到达目标，从而实现精确成像
各治疗领域对医药产品的需求日益增加
全球新发疾病病例的增多是医疗保健提供者的主要担忧。制药和生物制药公司每天都在努力应对与各种疾病相关的挑战。市场参与者越来越愿意提供各种用于不同配方的放射性药物产品，这推动了市场的增长。
与年龄、人口类型、遗传和慢性传染病相关的疾病患病率不断上升，这是导致放射性药物产品需求不断增加的主要因素。放射性药物已被描述用于诊断炎症性慢性疾病，并且已对几种肽、受体配体和单克隆抗体进行了放射性标记，从而可以在细胞和分子水平上对体内炎症过程进行可视化。
例如，
- 2019 年 2 月，根据 NCBI 文章，最近的一些发展表明，放射性药物治疗有望成为一种重要且得到广泛认可的治疗方式，它能够向肿瘤细胞递送细胞毒性辐射，而不会引起正常组织毒性
机会
放射性药物研发费用不断上升
技术进步包括提高传统药物的稳定性和强度。生物技术和制药公司不断投资于研发，为客户提供诊断和药物的创新服务，并提高其市场占有率。放射性药物在临床开发中发挥着积极作用。虽然诊断行业由于新技术在市场上的实施而处于不断波动的状态，但制药和生物技术行业继续增长，这是因为放射性药物公司的投资增加以及并购采用成像技术的创新来支持各种疾病的临床试验。
克制/挑战
- 与放射性药物相关的潜在风险
人类长期吸入铀和氡与呼吸系统疾病有关，例如慢性肺病，而镭暴露则会导致急性白细胞减少症、贫血、颌骨坏死和其他影响。放射性元素镭看起来像钙分子，它会被吸收到身体骨周转率高的区域，例如癌症正在生长的器官区域，除此之外，放射性药物还涉及一些程序风险。
最新动态
• 2022 年 10 月，Cardinal Health 通过一项由约 60,000 名在美国公司工作的美国员工进行的独立调查，被《福布斯》评为 2022 年美国最佳大型雇主公司之一。该公司认为这将激励他们，并激励他们的员工
- 2022 年 12 月，诺华获得欧盟委员会批准，将 Pluvicto 作为首个用于治疗前列腺癌的靶向放射性配体疗法。该公司认为，这将有助于推进广泛的放射性配体疗法组合，以治疗癌症
- 2024 年 8 月，领先的专注于放射性药物的公司 Lantheus Holdings, Inc.（“Lantheus”）致力于帮助临床医生发现、对抗和追踪疾病，以提供更好的患者治疗效果，该公司今天宣布，明尼苏达州罗切斯特市梅奥诊所放射性药物试验主任兼肿瘤内科学教授 Oliver Sartor 医学博士将在 2024 年 9 月 15 日星期日于巴塞罗那举行的欧洲肿瘤内科学会 (ESMO) 年会上进行口头报告，其中包括来自 PNT2002 2023 年 12 月初始读数的其他临床数据
- 2024 年 7 月，ANSTO 和伍伦贡大学开发了一种四重 MOSFET 设备，用于硼中子俘获疗法的实时质量控制。这种创新工具通过区分中子能级来提高精度，从而提高癌症治疗的安全性和有效性
亚太放射性药物市场范围
亚太放射性药物市场根据类型、应用、药物类型、来源和最终用户分为八个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
类型
- 诊断放射性药物
- 治疗性放射性药物
根据类型，亚太放射性药物市场分为诊断放射性药物和治疗放射性药物。
应用
- 诊断
- 治疗
根据应用，亚太放射性药物市场分为诊断和治疗。
药物类型
- 品牌
- 泛型
根据药物类型，亚太放射性药物市场分为仿制药和品牌药。
来源
- 核反应堆
- 回旋加速器
- 其他的
根据来源，亚太放射性药物市场分为核反应堆、回旋加速器和其他。
最终用户
- 医院
- 诊断中心
- 癌症研究机构
- 门诊手术中心
- 其他的
根据最终用户，亚太放射性药物市场分为医院、诊断中心、癌症研究机构、门诊手术中心和其他。
亚太放射性药物市场区域分析/见解
对亚太放射性药物市场进行分析，并根据类型、应用、药物类型、来源和最终用户提供市场规模洞察和趋势。
本市场报告涵盖的国家包括中国、日本、澳大利亚、韩国、新加坡、印度、印度尼西亚、菲律宾、马来西亚、越南和亚太地区其他地区。
由于中国人口众多、医疗支出不断增加、制药行业不断扩张、消费者意识不断增强、治疗需求不断增加，加上医疗保健基础设施不断发展和患病率不断上升，预计中国将在亚太市场占据主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和亚太放射性药物市场份额分析
亚太放射性药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、区域业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对亚太放射性药物市场的关注有关。
亚太地区放射性药物市场的一些主要参与者包括 Cardinal Health、Advanced Accelerator Applications、Lantheus、Curium、GE HealthCare、Jubilant Radiopharma（Jubilant Pharma 旗下公司）、Ansto、Eli Lilly And Company、Bayer AG、Siemens Healthcare Gmbh、中国、isotope & Radiation Corporation、Bracco、NTP、Eckert & Ziegler、Eczacıbaşı-Monrol、IBA Worldwide、BWX Technologies. Inc、Isotope JSC、Sterigenics US, LLC 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC RADIOPHARMACEUTICALS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET TESTING TYPE COVERAGE GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSIS
4.2 PORTER FIVE FORCES
5 REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 THE GROWING DEMAND FOR RADIOPHARMACEUTICALS IN DIAGNOSTICS AND CLINICAL USE
6.1.2 THE INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS
6.1.3 THE INCREASING PREVALENCE OF CHRONIC DISEASES
6.2 RESTRAINTS
6.2.1 STRINGENT REGULATIONS FOR RADIOPHARMACEUTICALS
6.2.2 POTENTIAL RISKS ASSOCIATED WITH RADIOPHARMACEUTICALS
6.3 OPPORTUNITIES
6.3.1 THE RISING RESEARCH AND DEVELOPMENT EXPENDITURE OF RADIOPHARMACEUTICALS
6.3.2 THE GROWING INCIDENCES OF COMPLEX DISEASES IN GERIATRIC POPULATION
6.4 CHALLENGES
6.4.1 HIGH COST OF DEVELOPMENT AND IMPLEMENTATION OF RADIOPHARMACEUTICALS
6.4.2 LACK OF TECHNICAL EXPERTISE AND HIGH COST FOR TRAINING EXISTING WORKFORCE
7 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE
7.1 OVERVIEW
7.2 BRANDED
7.3 GENERICS
8 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE
8.1 OVERVIEW
8.2 DIAGNOSTIC RADIOPHARMACEUTICALS
8.2.1 PET RADIOPHARMACEUTICALS
8.2.1.1 F-18
8.2.1.2 RU-82
8.2.1.3 OTHER PET ISOTOPES RADIOPHARMACEUTICALS
8.2.2 SPECT RADIOPHARMACEUTICALS
8.2.2.1 TECHNETIUM-99M
8.2.2.2 GALLIUM-67
8.2.2.3 IODINE-123
8.2.2.4 THALLIUM-201
8.2.2.5 OTHER SPECT ISOTOPES
8.3 THERAPEUTIC RADIOPHARMACEUTICALS
8.3.1 BRACHYTHERAPY ISOTOPES
8.3.1.1 IODINE-125
8.3.1.2 PALLADIUM-103
8.3.1.3 CESIUM-131
8.3.1.4 IRIDIUM-192
8.3.1.5 OTHER BRACHYTHERAPY ISOTOPES
8.3.2 BETA EMITTERS
8.3.2.1 IODINE-131
8.3.2.2 LUTHETIUM-177
8.3.2.3 SAMARIUM-153
8.3.2.4 YTTRIUM-90
8.3.2.5 RHENIUM-186
8.3.2.6 OTHER BETA EMITTERS
8.3.3 ALPHA EMITTERS
8.3.3.1 RA-223
8.3.3.2 OTHERS
9 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DIAGNOSTIC
9.2.1 ONCOLOGY
9.2.2 CARDIOLOGY
9.2.3 NEUROLOGY
9.2.4 BONE SCANS
9.2.5 THYROID APPLICATIONS
9.2.6 PULMONARY SCANS
9.2.7 OTHERS
9.3 THERAPEUTIC
9.3.1 THYROID INDICATIONS
9.3.2 BONE METASTASIS
9.3.3 LYMPHOMA
9.3.4 ENDOCRINE TUMORS
9.3.5 OTHER INDICATIONS
10 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY SOURCE
10.1 OVERVIEW
10.2 NUCLEAR REACTORS
10.3 CYCLOTRONS
10.4 OTHERS
11 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.2.1 PUBLIC
11.2.2 PRIVATE
11.2.2.1 DIAGNOSTIC CENTERS
11.2.2.2 CANCER RESEARCH INSTITUTES
11.2.2.3 AMBULATORY SURGICAL CENTERS
11.2.2.4 OTHERS
12 APAC RADIOPHARMACEUTICALS MARKET, BY COUNTRY
12.1 ASIA-PACIFIC
13 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 CARDINAL HEALTH
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENT
15.2 ADVANCED ACCELERATOR APPLICATIONS, A NOVARTIS COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 LANTHEUS
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 CURIUM
15.4.1 COMPANY SNAPSHOT
15.4.2 PRODUCT PORTFOLIO
15.4.3 RECENT DEVELOPMENT
15.5 GE HEALTHCARE
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ANSTO
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT UPDATES
15.7 BAYER AG
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BRACCO
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BWX TECHNOLOGIES. INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 CHINA ISOTOPE & RADIATION CORPORATION
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 ELI LILLY AND COMPANY
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ECKERT & ZIEGLER
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 GLOBAL MEDICAL SOLUTIONS
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 ECZACIBAŞI-MONROL
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 IBA WORLDWIDE
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 ISOTOPE JSC
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 JUBILANT RADIOPHARMA A JUBILANT PHARMOVA COMPANY
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 MALLINCKRODT PHARMACEUTICALS
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT UPDATES
15.19 NTP
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 SIEMENS HEALTHCARE GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENT
15.21 STERIGENICS U.S., LLC – A SOTERA HEALTH COMPANY
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 2 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 3 ASIA-PACIFIC DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 4 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 5 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 6 ASIA-PACIFIC PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 7 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 8 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 9 ASIA-PACIFIC SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 10 ASIA-PACIFIC THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 11 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 12 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 13 ASIA-PACIFIC BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 14 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 15 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 16 ASIA-PACIFIC BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 17 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 18 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 19 ASIA-PACIFIC ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 20 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 21 ASIA-PACIFIC DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 22 ASIA-PACIFIC THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 23 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 24 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 25 ASIA-PACIFIC HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 27 CHINA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 28 CHINA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 29 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 30 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 31 CHINA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 32 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 33 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 34 CHINA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 35 CHINA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 36 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 37 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 38 100
TABLE 39 CHINA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 40 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 41 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 42 CHINA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 43 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 44 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 45 CHINA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 46 CHINA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 47 CHINA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 48 CHINA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 49 CHINA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 50 CHINA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 51 CHINA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 52 CHINA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 53 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 54 AUSTRALIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 55 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 56 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 57 AUSTRALIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 58 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 59 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 60 AUSTRALIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 61 AUSTRALIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 62 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 63 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 64 AUSTRALIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 65 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 66 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 67 AUSTRALIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 68 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 69 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 70 AUSTRALIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 71 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 72 AUSTRALIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 73 AUSTRALIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 74 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 75 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 76 AUSTRALIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 77 AUSTRALIA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 78 JAPAN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 79 JAPAN DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 80 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 81 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 82 JAPAN PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 83 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 84 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 85 JAPAN SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 86 JAPAN THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 87 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 88 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 89 JAPAN BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 90 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 91 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 92 JAPAN BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 93 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 94 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 95 JAPAN ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 96 JAPAN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 97 JAPAN DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 98 JAPAN THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 99 JAPAN RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 100 JAPAN RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 101 JAPAN RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 102 JAPAN HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 103 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 104 SOUTH KOREA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 105 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 106 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 107 SOUTH KOREA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 108 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 109 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 110 SOUTH KOREA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 111 SOUTH KOREA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 112 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 113 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 114 SOUTH KOREA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 115 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 116 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 117 SOUTH KOREA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 118 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 119 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 120 SOUTH KOREA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 121 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 122 SOUTH KOREA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 123 SOUTH KOREA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 124 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 125 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 126 SOUTH KOREA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 127 SOUTH KOREA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 128 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 129 SINGAPORE DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 130 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 131 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 132 SINGAPORE PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 133 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 134 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 135 SINGAPORE SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 136 SINGAPORE THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 137 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 138 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 139 SINGAPORE BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 140 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 141 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 142 SINGAPORE BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 143 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 144 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 145 SINGAPORE ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 146 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 147 SINGAPORE DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 148 SINGAPORE THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 149 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 150 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 151 SINGAPORE RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 152 SINGAPORE HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 153 INDIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 154 INDIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 155 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 156 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 157 INDIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 158 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 159 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 160 INDIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 161 INDIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 162 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 163 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 164 INDIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 165 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 166 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 167 INDIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 168 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 169 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 170 INDIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 171 INDIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 172 INDIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 173 INDIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 174 INDIA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 175 INDIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 176 INDIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 177 INDIA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 178 INDONESIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 179 INDONESIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 180 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 181 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 182 INDONESIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 183 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 184 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 185 INDONESIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 186 INDONESIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 187 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 188 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 189 INDONESIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 190 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 191 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 192 INDONESIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 193 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 194 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 195 INDONESIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 196 INDONESIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 197 INDONESIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 198 INDONESIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 199 INDONESIA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 200 INDONESIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 201 INDONESIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 202 INDONESIA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 203 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 204 PHILIPPINES DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 205 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 206 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 207 PHILIPPINES PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 208 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 209 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 210 PHILIPPINES SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 211 PHILIPPINES THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 212 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 213 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 214 PHILIPPINES BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 215 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 216 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 217 PHILIPPINES BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 218 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 219 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 220 PHILIPPINES ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 221 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 222 PHILIPPINES DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 223 PHILIPPINES THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 224 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 225 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 226 PHILIPPINES RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 227 PHILIPPINES HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 228 THAILAND RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 229 THAILAND DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 230 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 231 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 232 THAILAND PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 233 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 234 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 235 THAILAND SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 236 THAILAND THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 237 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 238 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 239 THAILAND BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 240 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 241 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 242 THAILAND BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 243 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 244 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 245 THAILAND ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 246 THAILAND RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 247 THAILAND DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 248 THAILAND THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 249 THAILAND RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 250 THAILAND RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 251 THAILAND RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 252 THAILAND HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 253 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 254 MALAYSIA DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 255 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 256 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 257 MALAYSIA PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 258 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 259 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 260 MALAYSIA SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 261 MALAYSIA THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 262 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 263 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 264 MALAYSIA BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 265 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 266 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 267 MALAYSIA BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 268 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 269 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 270 MALAYSIA ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 271 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 272 MALAYSIA DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 273 MALAYSIA THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 274 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 275 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 276 MALAYSIA RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 277 MALAYSIA HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 278 VIETNAM RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 279 VIETNAM DIAGNOSTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 280 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 281 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 282 VIETNAM PET RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 283 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 284 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 285 VIETNAM SPECT RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 286 VIETNAM THERAPEUTIC RADIOPHARMACEUTICALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 287 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 288 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 289 VIETNAM BRACHYTHERAPY ISOTOPES IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 290 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 291 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 292 VIETNAM BETA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 293 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 294 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (VOLUME IN MBQ)
TABLE 295 VIETNAM ALPHA EMITTERS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (ASP PER MBQ)
TABLE 296 VIETNAM RADIOPHARMACEUTICALS MARKET, BY APPLICATION, 2022-2031 (USD MILLION)
TABLE 297 VIETNAM DIAGNOSTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 298 VIETNAM THERAPEUTIC IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 299 VIETNAM RADIOPHARMACEUTICALS MARKET, BY DRUG TYPE, 2022-2031 (USD MILLION)
TABLE 300 VIETNAM RADIOPHARMACEUTICALS MARKET, BY SOURCE, 2022-2031 (USD MILLION)
TABLE 301 VIETNAM RADIOPHARMACEUTICALS MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 302 VIETNAM HOSPITALS IN RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 303 REST OF ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET, BY TYPE, 2022-2031 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC RADIOPHARMACEUTICALS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: MARKET TESTING TYPE COVERAGE GRID
FIGURE 9 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: SEGMENTATION
FIGURE 11 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET:
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 THE RISING PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET IN THE FORECAST PERIOD
FIGURE 15 THE TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET IN 2024 & 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY DRUG TYPE, 2023
FIGURE 18 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY DRUG TYPE, 2024-2031 (USD MILLION)
FIGURE 19 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY DRUG TYPE, CAGR (2024-2031)
FIGURE 20 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY TYPE, 2023
FIGURE 22 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY TYPE, 2024-2031 (USD MILLION)
FIGURE 23 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 24 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY APPLICATION, 2023
FIGURE 26 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 27 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY SOURCE, 2023
FIGURE 30 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY SOURCE, 2024-2031 (USD MILLION)
FIGURE 31 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY SOURCE, CAGR (2024-2031)
FIGURE 32 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY SOURCE, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY END USER, 2023
FIGURE 34 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 35 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY END USER, CAGR (2024-2031)
FIGURE 36 ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 APAC RADIOPHARMACEUTICALS MARKET BY SNAPSHOT
FIGURE 38 AISA-PACIFIC RADIOPHARMACEUTICALS MARKET: COMPANY SHARE 2023 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
